Apo Ibuprofen

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Apo Ibuprofen

Property Description
Active Ingredient Ibuprofen
Form Oral tablets, capsules, suspension, or topical gel
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common Purpose Symptomatic relief of pain, inflammation, and fever
Origin Synthetic compound

What Type of Medicine is Apo Ibuprofen?

Apo Ibuprofen is a medicinal preparation whose active ingredient is Ibuprofen, a core substance fundamentally classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This classification denotes that the drug possesses the triple capacity to act as an analgesic (pain reliever), an anti-inflammatory agent, and an antipyretic (fever reducer). Ibuprofen is chemically defined as a synthetic propionic acid derivative, a classification which establishes its mechanism of action and differentiates it from simple analgesics like acetaminophen, which lacks significant anti-inflammatory properties. Pharmacological studies routinely confirm the effectiveness of this class for targeting inflammation. Ibuprofen is a well-established NSAID used for its ability to target and reduce inflammation. This confirmation indicates that the medicine is effective at easing discomfort that often arises from managing conditions such as a common headache or muscle strain. This specific pharmacological grouping clarifies that Apo Ibuprofen is engineered to address discomfort where pain is associated with an inflammatory process.


Composition, Forms, and General Purpose

The active component, Ibuprofen, is a purely synthetic compound, manufactured through industrial processes to ensure consistent purity and structure. Apo Ibuprofen is a brand focusing on the INN Ibuprofen, and while available in numerous oral preparations, it is often marketed with variations in tablet format or pediatric suspensions designed to meet the needs of diverse patient groups. The medication is commonly supplied in various dosage forms, including oral preparations such as tablets, capsules, and oral suspensions, alongside topical gels designed for external application. Ibuprofen is recognized for its established importance in symptomatic care. The general purpose of Apo Ibuprofen is to provide rapid, temporary symptomatic relief by mitigating the three core physical responses—pain, fever, and inflammation—rather than curing the underlying condition.

Regulatory References

  1. MedlinePlus, NIH
  2. WHO Essential Medicines

What side effects are possible with Apo Ibuprofen?

Possible Side Effects and Safety Information

Apo Ibuprofen, like all Nonsteroidal Anti-inflammatory Drugs (NSAIDs), is associated with a range of possible side effects, some of which can be serious and clinically significant. Regulatory authorities emphasize two primary serious risks: Cardiovascular Thrombotic Events and Gastrointestinal Complications.


Serious Adverse Reactions (Warnings)

  • Cardiovascular: NSAIDs may increase the risk of serious, potentially fatal, cardiovascular thrombotic events, including heart attack (myocardial infarction) and stroke. This risk can increase with higher doses (specifically 2400 mg/day or greater) and longer duration of use. The drug is contraindicated for use right before or after coronary artery bypass graft (CABG) surgery.
  • Gastrointestinal: The drug can cause serious gastrointestinal adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which may be fatal. This risk is higher in older patients and those with a history of GI bleeding or ulcers.
  • Hypersensitivity: Severe allergic and anaphylactic reactions, along with serious skin reactions (e.g., Stevens-Johnson Syndrome), are documented and require immediate medical attention.

Commonly Reported Adverse Reactions

Side effects involving the gastrointestinal system are most common, including nausea, vomiting, diarrhea, heartburn, constipation, and abdominal pain. Other documented effects include dizziness, headache, tinnitus (ringing in the ears), and fluid retention.

Population-Specific Safety Considerations

  • Pregnancy: Use of Apo Ibuprofen is generally advised against from 20 weeks gestation or later due to the risk of fetal kidney problems (renal dysfunction) leading to low amniotic fluid (oligohydramnios). It is contraindicated in the third trimester (28 weeks or later).
  • Elderly: Patients aged 60 or older are at a higher risk of serious gastrointestinal bleeding. Monitoring for kidney function may be required.

To mitigate known risks, official guidelines recommend using the lowest effective dose for the shortest possible duration necessary to achieve therapeutic goals.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving Ibuprofen (the active component of Apo Ibuprofen) is formally documented in regulatory labeling with a range of clinical manifestations. Initial signs often involve the gastrointestinal system (abdominal pain, nausea, vomiting, diarrhoea) and the Central Nervous System (CNS), presenting as headache, dizziness, somnolence, nystagmus, and tinnitus. Diarrhoea is cited as a more frequent manifestation in the pediatric population.

More severe overexposure carries a documented risk for serious, life-threatening outcomes. These complications, as stated in official regulatory sources, include convulsions, coma, severe hypotension, acute renal failure, and metabolic acidosis. Patients with pre-existing renal or hepatic impairment may be at increased risk for severe complications following overdose.

The official regulatory guidance requires that individuals seek immediate medical attention for any suspected overdose. Because no specific antidote is known for Ibuprofen toxicity, management is strictly focused on symptomatic and supportive treatment. Procedures such as administering activated charcoal within one hour of ingestion of a potentially toxic amount are described as options. Hospital monitoring for several hours is required to continuously observe vital signs and renal function and to manage the severe, officially documented systemic complications.

Therapeutic Uses of Apo Ibuprofen

Apo Ibuprofen may be part of symptomatic management, applied across domains where additional symptomatic support is needed during episodes of acute or recurrent discomfort. The medication is commonly used to help with symptoms related to systemic imbalance, such as elevated body temperature (fever), and is applied in addressing discomfort related to inflammatory or irritative states.

The medication is relevant across acute therapeutic contexts involving systemic or localized discomfort. This includes symptoms associated with conditions like tension headaches, certain migraine headaches, dental pain, musculoskeletal strains, and the discomfort of primary dysmenorrhea (menstrual cramps).

“It is applied during phases of increased distress or discomfort, providing supportive relief when symptoms interfere with routine activities.”

The symptomatic relief is relevant for easing symptoms related to heightened physiological activity (fever) and helps address symptom clusters associated with acute or episodic changes (pain and inflammation). Apo Ibuprofen contributes to easing the overall symptom load, supports patients during difficult episodes by easing distress.


Quick Fact: Supportive Relief for Pain, Fever, and Inflammation


Regulatory References

  1. Health Canada Drug and Health Product Register

Eligibility and Restrictions for Use

Who can and cannot use Apo Ibuprofen?

The eligibility for using Apo Ibuprofen (Ibuprofen) is strictly defined by regulatory bodies based on a patient’s health status, age, and pregnancy status. Use is generally established for adults and children/adolescents above specific minimum age thresholds.

Contraindications and Restrictions

Apo Ibuprofen is absolutely contraindicated (must not be used) in several populations to prevent severe health risks:

  • Hypersensitivity: Individuals with a history of allergic reactions to Ibuprofen, Aspirin (ASA), or other NSAIDs.
  • Severe Organ Dysfunction: Patients with active or recurrent gastrointestinal (GI) ulceration or bleeding, severe, uncontrolled heart failure, severe renal impairment, or severe hepatic impairment.
  • Pregnancy: Use is contraindicated during the third trimester of pregnancy (after 20-30 weeks' gestation).

Age and Condition-Based Eligibility

Population Group Official Regulatory Status
Infants Use is not established or not recommended for infants typically under 3 to 6 months of age.
Older Adults (ge 65) Use is conditional; lowest effective dose for the shortest duration is recommended due to higher documented risk.
Conditional Use Patients with non-severe organ impairment, history of GI disease, or hypertension require special medical consideration and restricted use.

Use is generally compatible with breastfeeding when taken at recommended doses.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interactions with other substances as documented in official government drug labels. Apo Ibuprofen, containing the active ingredient Ibuprofen, is subject to specific regulatory constraints based on pharmacokinetic and pharmacodynamic interactions.

Documented Interaction Patterns

Formal Contraindications and Restrictions: Co-administration with other NSAIDs (including COX-2 inhibitors) should be avoided due to the documented increase in the risk of adverse gastrointestinal events. Ibuprofen is formally contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Interactions Affecting Clearance and Exposure: Ibuprofen reduces the renal clearance of certain co-administered medicines, such as Lithium and Methotrexate. This effect leads to a documented increase in the plasma concentrations of these drugs. It may also increase the plasma levels of Cardiac Glycosides.

Pharmacodynamic Risk Augmentation: Ibuprofen enhances the effects of Anticoagulants (e.g., Warfarin), increasing the risk of serious bleeding. Co-administration with Antiplatelet Agents and Selective Serotonin Reuptake Inhibitors (SSRIs) also poses an additive risk of gastrointestinal bleeding. Concomitant use with Oral Corticosteroids increases the risk of gastrointestinal ulceration. Ibuprofen can also diminish the efficacy of Antihypertensives and Diuretics.

Timing Requirements: To avoid interference with the cardioprotective effect of immediate-release low-dose Aspirin, regulatory guidelines mandate a separation of administration: Ibuprofen must be taken at least 8 hours before or 30 minutes after the aspirin dose. Furthermore, alcohol use concurrently increases the documented risk of gastrointestinal bleeding.

Mechanism of Action

Molecular Blockade of Cyclooxygenase (COX) Enzymes

The primary action of Ibuprofen is the non-selective competitive inhibition of the Cyclooxygenase ( COX-1 and COX-2) enzymes. This molecular blockade directly interrupts the Arachidonic Acid Pathway, thereby restricting the synthesis of signaling molecules called Prostaglandins. This fundamental step defines the drug's primary physiological effects, as Prostaglandins are central mediators in several key bodily responses.

Modulation of Nociceptive and Vascular Signaling

By reducing the level of Prostaglandins at an injury site, the drug induces two main physiological consequences. First, it diminishes the sensitization of peripheral nociceptors (pain-sensing nerves), which results in reduced signal transmission. Second, it restricts the Prostaglandin-driven vasodilation and increased capillary permeability, reducing localized fluid and protein extravasation characteristic of the vascular phase of inflammation.

Hypothalamic Thermoregulatory Control

The drug's mechanism extends to the central nervous system, specifically the hypothalamus, the region responsible for controlling body temperature. In this area, the mechanism suppresses the production of PGE2 that is triggered by pyrogens during illness. This action results in the resetting of the body's elevated thermoregulatory set point, initiating the physiological mechanisms required for heat dissipation and the establishment of thermal equilibrium.

Dosage and Administration Information

Instruction Map: How to use Apo Ibuprofen

This map outlines the instructions for the administration of Ibuprofen as found in product labeling.


Administration Scope

Feature Description
Route of Administration Oral (tablets, capsules, suspension), Intravenous (Parenteral, administered by infusion), and Topical (Gel or cream).
Dosing Schedule OTC: 200 mg to 400 mg per dose; Maximum daily dose 1200 mg for adolescents and adults. Prescription: Maximum daily dose 3200 mg when administered in divided doses.
Frequency and Timing The dose may be repeated every 4 to 6 hours as needed, ensuring a minimum interval of 4 hours is maintained between administrations.
Timing in relation to meals May be administered with food or milk to help minimize potential gastric discomfort, as specified in product labeling.
Preparation requirements Oral suspension and drops must be shaken well before use. The dose must be accurately measured using the calibrated dosing device provided with the product.
Age-group administration rules Pediatric: Dosing for children is typically weight-based (5 mg/kg to 10 mg/kg per dose), not to exceed 4 doses in 24 hours.
Special procedural conditions The standard usage principle is to use the lowest effective dose for the shortest duration necessary. Specific oral forms should be swallowed whole and must not be chewed, crushed, or sucked.

Connection to the overall use protocol

These instructions define a protocol for administration, establishing the delivery methods (oral, IV, topical) and the specific numerical dosage limits and scheduling patterns. The protocol details practical administration steps, such as taking the dose with food or properly preparing liquid forms, ensuring the medicine is used consistently.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Apo Ibuprofen

Evidence for Acute Pain and Fever Management

A substantial body of research has explored the role of Apo Ibuprofen in studying outcomes related to physical discomfort (acute pain) and addressing outcomes related to systemic imbalance (fever). This evidence base is primarily built upon numerous Randomized Controlled Trials (RCTs) and meta-analyses that examined this agent against placebo and other common symptom relievers. These studies were applied in research contexts involving fluctuating or unstable symptoms over short time periods, with a high evidence level as described by regulatory bodies.

Evidence for Specific Acute Pain States

Focused research was evaluated in specific clinical situations characterized by conditions associated with acute or disruptive episodes. These include studies conducted during periods of increased symptom activity related to dental procedures, discomfort associated with primary dysmenorrhea (menstrual cramps), and pain linked to soft tissue and musculoskeletal injuries. The established research base is robust for short-term, acute symptom evaluation, but long-term effects are not fully established for individuals who use the agent over many years to manage recurrent episodic pain. Follow-up durations were limited to the short-term course of the acute symptoms.

Research Landscape for Inflammatory Conditions

Research was studied for its potential role in studying symptoms of conditions involving periods of heightened symptoms that include inflammation, such as osteoarthritis. The key outcomes linked to inflammatory or irritative states included functional metrics like joint mobility and patient global assessments of discomfort. The evidence level assigned for chronic inflammatory relief evaluation is typically moderate, reflecting greater complexity and a mix of study designs compared to acute relief studies.

Research Gaps and Uncertainties

Despite the high volume of research, the evidence highlights what is known — and what is still uncertain. The major limitation is that follow-up durations were limited in many acute efficacy trials, meaning long-term effects are not fully established regarding recurrent use. While extensive data show patterns related to short-term symptom patterns, the evidence quality varies across studies when analyzing specific, smaller patient subgroups. Research provides context but not individual predictions, as study results reflect only the specific conditions under which they were conducted.

Key Studies & References

  1. Ibuprofen: MedlinePlus Drug Information
  2. WHO Model List of Essential Medicines

Frequently Asked Questions (FAQ)

Common questions about Apo Ibuprofen (FAQ)

Q: Why do some people need a prescription for Apo Ibuprofen when others can buy it at the store?

A: Apo Ibuprofen (Ibuprofen) is available as both an Over-the-Counter (OTC) product and a Prescription product. This regulatory distinction is based primarily on the dosage. Lower strengths are available OTC because their maximum daily dose is deemed safe for unsupervised use, whereas higher doses require a prescription due to the increased risk associated with greater potency.

Q: Is Apo Ibuprofen different from regular ibuprofen?

A: Apo Ibuprofen is a brand name for a medicine whose active ingredient is ibuprofen. Official information indicates that the therapeutic effect comes from the active ingredient. While the active ingredient is the same, variations may exist in the inactive ingredients (excipients) and the specific formulation used by the manufacturer.

Q: How quickly does Apo Ibuprofen start to work for pain?

A: Official regulatory studies monitor the drug’s absorption into the body. The time required to reach the maximum concentration in the blood is typically reported to be between one to two hours for standard oral formulations, which is a key measure used to estimate the onset of action.

Q: How long does the effect of Apo Ibuprofen typically last?

A: The dosage instructions for oral formulations typically advise repeating the dose every four to six hours as needed. This recommended time interval is established by regulatory bodies and reflects the drug's expected duration of effect.

Q: What are the most commonly reported side effects of Apo Ibuprofen?

A: According to official product information, commonly reported side effects include gastrointestinal effects such as nausea, vomiting, abdominal pain, and indigestion (dyspepsia), as well as headache and dizziness.

Q: Is it common to feel drowsy or tired when taking Apo Ibuprofen?

A: Regulatory documents list both somnolence (drowsiness) and insomnia (trouble sleeping) as possible documented side effects. Regulatory information consistently notes that any questions about possible side effects should be addressed by a healthcare provider.

Q: Can Apo Ibuprofen cause ringing in the ears (tinnitus)?

A: Yes, regulatory documents list tinnitus, or ringing in the ears, as a possible documented side effect of Apo Ibuprofen. This is often classified in official product information as an uncommon or rare event.

Q: Is Apo Ibuprofen considered a narcotic or opioid?

A: No. Official regulatory classification (such as the DEA schedule in the U.S.) identifies Ibuprofen as a drug with no scheduling requirements. This confirms that it is not considered a narcotic or opioid substance.

Q: Does Apo Ibuprofen have a potential for dependence or misuse?

A: The regulatory status of Ibuprofen as a non-scheduled substance supports that it does not carry a known potential for dependence or misuse in the manner of controlled substances. This status is based on the drug's established pharmacological profile.

Q: Are there any common foods or drinks that should be avoided when taking Apo Ibuprofen?

A: The product label includes an explicit Alcohol Warning. This advisory cautions against concomitant use with three or more alcoholic drinks daily due to a documented increase in the risk of stomach bleeding.

Q: Is it safe to take Apo Ibuprofen if I am also taking an antidepressant?

A: Regulatory documents indicate that combining non-steroidal anti-inflammatory drugs (NSAIDs) with certain antidepressants, specifically Selective Serotonin Reuptake Inhibitors (SSRIs), may increase the risk of gastrointestinal bleeding. Reviewing all concurrent medications with a healthcare provider remains the recommended practice described in regulatory documents.

Q: Does Apo Ibuprofen interact with herbal supplements like St. John's Wort?

A: Regulatory documents advise that certain herbal supplements, such as St. John's Wort, may interact with how other medicines are processed in the body. Regulatory guidance often suggests discussing all supplements and non-prescription products with a healthcare provider before use.

Q: What should I do if I suspect an interaction between Apo Ibuprofen and another medicine?

A: If you suspect an interaction or experience any unexpected symptoms after combining medicines, the official patient label states that seeking the advice of a healthcare provider or pharmacist is the appropriate course of action.

Q: Is there a maximum time Apo Ibuprofen should be taken continuously?

A: For unsupervised use, the product label typically specifies a maximum duration. For pain relief, this is usually advised not to exceed ten days, and for fever, not to exceed three days, unless a healthcare provider directs otherwise.

Q: What if I forget a dose of Apo Ibuprofen (non-directive question)?

A: The standard instruction provided in the patient information leaflet is to simply resume the usual schedule for the next dose. Regulatory guidance on missed doses typically advises against taking a double dose to compensate for the missed one.

Q: Does Apo Ibuprofen contain penicillin or related antibiotics?

A: The required list of active and inactive ingredients on the product label does not list penicillin or any antibiotic as a component of the drug formulation.

Q: Is Apo Ibuprofen gluten-free?

A: The official labeling for certain formulations of ibuprofen states that they contain no ingredient made from a gluten-containing grain (such as wheat, barley, or rye).

Q: How does Apo Ibuprofen affect fever?

A: The drug acts as an antipyretic by temporarily inhibiting the body's synthesis of signaling molecules called prostaglandins in the brain's temperature-regulating center. This helps to reset the body’s elevated temperature set point.

Q: Why is Apo Ibuprofen sometimes described as an anti-inflammatory and other times as a painkiller?

A: Regulatory documents confirm that Ibuprofen possesses both analgesic (pain-relieving) and anti-inflammatory properties. This dual function, which results from its core mechanism of action, is why it is referred to by both terms.

Q: What evidence exists regarding Apo Ibuprofen and surgical recovery pain?

A: Official documents indicate the drug is used for acute pain relief, but they also contain explicit warnings regarding use near certain surgical procedures. For example, it is contraindicated for use before or after Coronary Artery Bypass Graft (CABG) surgery.

Q: What evidence exists regarding Apo Ibuprofen and joint pain?

A: The product labeling lists relief of minor aches and pains due to conditions such as minor arthritis pain and joint pain as regulatory-approved indications (uses). This indicates that official evidence was evaluated for these specific uses.

Q: Do studies show Apo Ibuprofen is effective for menstrual cramps?

A: Yes, the product labeling lists temporary relief of minor aches and pains due to menstrual cramps as a regulatory-approved indication. This use is supported by the evidence reviewed by regulatory bodies.

Q: Can Apo Ibuprofen be used for tension headaches?

A: The product labeling lists temporary relief of minor aches and pains due to headache as a regulatory-approved indication. This general category includes tension headaches.

Q: Has there been much research on Apo Ibuprofen use in children?

A: Regulatory documents define specific age and weight-based dosing for children over a certain age, such as six months to twelve years. This is evidence that established research exists and has been reviewed for these pediatric populations.

Q: Does Apo Ibuprofen come in different forms (e.g., liquid, tablet)?

A: Yes, the drug is available in several regulatory-approved forms. These include oral formulations such as tablets, capsules, and oral suspension (liquid).

Q: How is the safety of Apo Ibuprofen monitored after it is released to the public?

A: Safety is continuously monitored by government authorities through established systems of Post-Market Surveillance. These systems mandate the ongoing collection and reporting of Adverse Drug Reactions (ADRs) by manufacturers.

Q: How does Apo Ibuprofen relate to other drugs in the 'propionic acid derivative' class?

A: Ibuprofen is chemically classified as a propionic acid derivative, placing it in the same chemical category as other non-steroidal anti-inflammatory drugs (NSAIDs) like naproxen. This classification defines its fundamental chemical structure and pharmacological action.

Q: Can children 2 years old use it?

A: The regulatory information includes specific dose tables for children by age and weight, typically covering the 2-year-old age range. This indicates that the use of Ibuprofen has been approved for this age range.

How should Apo Ibuprofen be stored and disposed of?

How to Store and Dispose of Apo-Ibuprofen

Official regulatory guidelines define strict conditions for the storage and disposal of Apo-Ibuprofen (Ibuprofen) tablets.

Storage Requirements

The medication must be stored at room temperature, maintained between 15 C and 30 C. The tablets must be kept in the original container, which should remain tightly closed, and protected from light and moisture.

Storage Factor Official Requirement
Temperature 15 C to 30 C
Container Keep tightly closed in original container
Safety Keep out of the reach and sight of children
Stability Do not use past the printed expiration date

Disposal Instructions

Disposal must strictly adhere to local and provincial regulatory requirements. The medicine must not be thrown into household trash or discarded via wastewater (sinks or toilets). Unused or expired products should be returned to a local pharmacist or a designated pharmaceutical take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Apo Ibuprofen found in:

A-Z Index: